Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvation Bio(NUVB) | 8,831,089 | 8,081,089 | -750,000 | 32,675 | 72,407 | 25.27% | +39,732 |
| Upstream Bio Inc. | 1,356,293 | 1,326,293 | -30,000 | 25,512 | 36,009 | 12.57% | +10,497 |
| enGene Holdings Inc. COM | 526,357 | 876,357 | +350,000 | 3,595 | 7,914 | 2.76% | +4,318 |
| Alumis Inc. | 653,223 | 653,223 | 0 | 2,606 | 6,375 | 2.23% | +3,769 |
| BridgeBio Oncology Therapeutics Inc. | 3,289,661 | 3,289,661 | 0 | 38,094 | 41,187 | 14.37% | +3,092 |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | 34,811 | 37,104 | 12.95% | +2,293 |
| Beta Bionics Inc. | 1,920,125 | 1,316,183 | -603,942 | 38,153 | 40,104 | 14.00% | +1,951 |
| Replimune Group(REPL) | 248,672 | 248,672 | 0 | 1,042 | 2,417 | 0.84% | +1,375 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 2,995 | 3,434 | 1.20% | +439 |
| enGene Holdings Inc. *W EXP 10/31/202 | 89,702 | 0 | -89,702 | 63 | 0 | — | -63 |
| ImageneBio, Inc. | 455,361 | 455,361 | 0 | 3,711 | 3,142 | 1.10% | -569 |
| Kestra Med Technologies Ltd SHS | 1,645,893 | 1,373,591 | -272,302 | 39,106 | 36,428 | 12.71% | -2,679 |